Document:

exv10w2

 

Exhibit 10.2

3,200,000 Shares

Citizens, Inc.

Class A Common Stock

(no par value)

PLACEMENT AGENT AGREEMENT

November 28, 2007

Oppenheimer & Co. Inc.

          As representative of the Placement Agents

          named in Schedule I hereto

125 Broad Street

New York, New York 10004

Dear Sirs:

     Citizens, Inc., a Colorado corporation (the “Company”), proposes to sell to the Purchasers,
pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription
Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered
into with the Purchasers identified therein (each a “Purchaser” and, collectively, the
“Purchasers”), up to an aggregate of 3,200,000 shares (the “Shares”) of the Company’s Class A
common stock, no par value (the “Common Stock”). The Company hereby confirms its agreement with
the placement agents named on Schedule I attached hereto (the “Placement Agents”) as set
forth below. Oppenheimer & Co. Inc. (“Oppenheimer”) is acting as the representative of the
Placement Agents and in such capacity is hereinafter referred to as the “Representative.” Certain
terms used herein are defined in Section 14 hereof:

1. Agreement to Act as Placement Agent; Placement of Securities. On the basis of the
representations, warranties and agreements of the Company herein contained, and subject to all the
terms and conditions of this Agreement:

	 	(a)	 	The Company hereby authorizes the Placement Agents to act as its exclusive
agents to solicit offers for the purchase of all or part of the Shares from the Company
in connection with the proposed offering of the Shares (the “Offering”). Until the
Closing Date (as defined in Section 3 hereof) or upon the termination of the
Offering, the Company shall not, without the prior written consent of the
Representative, solicit or accept offers to purchase the Shares otherwise than through
the Placement Agents.
	 
	 	(b)	 	The Placement Agents agree, as agents of the Company, to use their reasonable
best efforts to solicit offers to purchase the Shares from the Company on the terms and
subject to the conditions set forth in the Prospectus (as defined below). The
Placement Agents shall make commercially reasonable efforts to assist the

 

 

	 	 	 	Company in obtaining performance by each Purchaser whose offer to purchase Shares
has been solicited by the Placement Agents and accepted by the Company, but the
Placement Agents shall not, except as otherwise provided in this Agreement, be
obligated to disclose the identity of any potential purchaser or have any liability
to the Company in the event any such purchase is not consummated for any reason.
Under no circumstances will the Placement Agents be obligated to purchase any Shares
for their own account and, in soliciting purchases of Shares, the Placement Agents
shall act solely as the Company’s agents and not as principals. Notwithstanding the
foregoing and except as otherwise provided in Section 1(c) hereof, it is
understood and agreed that the Placement Agents (or their affiliates) may, solely at
their discretion and without any obligation to do so, purchase Shares as principals,
provided, however, that any such purchases by the Placement Agents
shall be subject to the prior approval of the Company, in its sole discretion, and
that such purchases are properly disclosed in the General Disclosure Package if
required under the securities laws.
	 
	 	(c)	 	Subject to the provisions of this Section 1, offers for the purchase of
Shares may be solicited by the Placement Agents as agents for the Company at such times
and in such amounts as the Placement Agents deem advisable. Each Placement Agent shall
communicate to the Company, orally or in writing, each reasonable offer to purchase
Shares received by it as agent of the Company. The Company shall have the sole and
absolute right to accept offers to purchase the Shares and may reject any such offer,
in whole or in part. Each Placement Agent shall have the right, in its discretion
reasonably exercised, without notice to the Company, to reject any offer to purchase
Shares received by it, in whole or in part, and any such rejection shall not be deemed
a breach of its agreement contained herein.
	 
	 	(d)	 	The purchases of the Shares by the Purchasers shall be evidenced by the
execution of the Subscription Agreements by each of the parties thereto.
	 
	 	(e)	 	As compensation for services rendered, on the Closing Date the Company shall
pay to the Placement Agents (or cause to be paid out of escrow) by wire transfer of
immediately available funds to an account or accounts designated by the Representative,
an amount equal to five and a half percent (5.5%) of the gross proceeds received by the
Company from the sale of the Shares on such Closing Date.
	 
	 	(f)	 	No Share which the Company has agreed to sell pursuant to this Agreement shall
be deemed to have been purchased and paid for, or sold by the Company, until such Share
shall have been delivered to the Purchaser thereof against payment by such Purchaser.
If the Company shall default in its obligations to deliver any Shares to a Purchaser
whose offer it has accepted, the Company shall indemnify and hold the Placement Agents
harmless against loss, claim or damage arising from or as a result of such default by
the Company in accordance with Section 7 hereof.

2. Representations and Warranties of the Company. The Company represents and warrants to,
and agrees with, the Placement Agents that:

2

 

	 	(a)	 	The Company has prepared and filed in conformity with the requirements of the
Securities Act of 1933, as amended (the “Securities Act”), and published rules and
regulations thereunder (the “Rules and Regulations”) adopted by the Securities and
Exchange Commission (the “Commission”) a “shelf” Registration Statement (as hereinafter
defined) on Form S-3 as amended (No. 333-143518), which became effective on June 22,
2007 (the “Effective Date”), including a base prospectus relating to the Shares (the
“Base Prospectus”), and such amendments and supplements thereto as may have been
required to the date of this Agreement. The term “Registration Statement” as used in
this Agreement means the registration statement (including all exhibits, financial
schedules and all documents and information deemed to be a part of the Registration
Statement pursuant to Rule 430 or 424(b) of the Rules and Regulations), as amended or
supplemented to the date of this Agreement, including the Base Prospectus. The
Registration Statement is effective under the Securities Act and no stop order
preventing or suspending the effectiveness of the Registration Statement or suspending
or preventing the use of the Prospectus has been issued by the Commission and, to the
knowledge of the Company, no proceedings for that purpose have been instituted or are
threatened by the Commission. The Company, if required by the Rules and Regulations,
proposes to file the Prospectus (as defined below), with the Commission pursuant to
Rule 424(b) of the Rules and Regulations. The term “Prospectus” as used in this
Agreement means the Prospectus, in the form in which it is to be filed with the
Commission pursuant to Rule 424(b) of the Rules and Regulations, or, if the Prospectus
is not to be filed with the Commission pursuant to Rule 424(b), the Prospectus in the
form included as part of the Registration Statement as of the Effective Date, except
that if any revised prospectus or prospectus supplement shall be provided to the
Placement Agents by the Company for use in connection with the offering and sale of the
Shares which differs from the Prospectus (whether or not such revised prospectus or
prospectus supplement is required to be filed by the Company pursuant to Rule 424(b) of
the Rules and Regulations), the term “Prospectus” shall refer to such revised
prospectus or prospectus supplement, as the case may be, from and after the time it is
first provided to the Placement Agents for such use. Any preliminary prospectus or
prospectus subject to completion included in the Registration Statement or filed with
the Commission pursuant to Rule 424 of the Rules and Regulations is hereafter called a
“Preliminary Prospectus.” Any reference herein to the Registration Statement, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the
documents incorporated by reference therein pursuant to Item 12 of Form S-3 which were
filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on or
before the last to occur of the Effective Date, the date of the Preliminary Prospectus,
or the date of the Prospectus, and any reference herein to the terms “amend,”
“amendment,” or “supplement” with respect to the Registration Statement, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include
(i) the filing of any document under the Exchange Act after the Effective Date, the
date of such Preliminary Prospectus or the date of the Prospectus, as the case may be,
which is incorporated by reference and (ii) any such document so filed, but excluding
any documents or information furnished to the

3

 

	 	 	 	Commission under Item 2.02 or Item 7.01 of any Current Report on Form 8-K. If the
Company has filed an abbreviated registration statement to register additional
Shares pursuant to Rule 462(b) under the Rules and Regulations (the “462(b)
Registration Statement”), then any reference herein to the Registration Statement
shall also be deemed to include such 462(b) Registration Statement.

	 	(b)	 	As of the Applicable Time (as defined below) and as of the Closing Date,
neither (i) the Pricing Prospectus (as defined below) and any information included on
Schedule II hereto (the “Pricing Information”) and the General Use Free Writing
Prospectus (as defined below), if any, issued at or prior to the Applicable Time, all
considered together (collectively, the “General Disclosure Package”), nor (ii) any
individual Limited Use Free Writing Prospectus (as defined below), if any, when
considered together with the General Disclosure Package, included or will include any
untrue statement of a material fact or omitted or will omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that the
Company makes no representations or warranties as to information contained in or
omitted from any Issuer Free Writing Prospectus in reliance upon, and in conformity
with, written information furnished to the Company by the Placement Agents through the
Representative specifically for inclusion therein, which information the parties hereto
agree is limited to the Placement Agents’ Information (as defined in Section 16
hereof). As used in this Section 2(b) and elsewhere in this Agreement:
	 
	 	 	 	“Applicable Time” means 4:30 P.M., New York time, on the date of this Agreement.
	 
	 	 	 	“Pricing Prospectus” means the Preliminary Prospectus, if any, and the Base
Prospectus, each as amended and supplemented as of immediately prior to the
Applicable Time, including any document incorporated by reference therein and any
prospectus supplement deemed to be a part thereof.
	 
	 	 	 	“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as
defined in Rule 433 under the Securities Act relating to the Shares in the form
filed or required to be filed with the Commission or, if not required to be filed,
in the form retained in the Company’s records pursuant to Rule 433(g) under the
Securities Act.
	 
	 	 	 	“General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that
is identified on Schedule III hereto.
	 
	 	 	 	“Limited Use Free Writing Prospectuses” means any Issuer Free Writing Prospectus
that is not a General Use Free Writing Prospectus.
	 
	 	(c)	 	No order preventing or suspending the use of any Preliminary Prospectus, any
Issuer Free Writing Prospectus or the Prospectus relating to the proposed offering of
the Shares has been issued by the Commission, and, to the knowledge of the

4

 

	 	 	 	Company, no proceeding for that purpose or pursuant to Section 8A of the Securities
Act has been instituted or is threatened by the Commission. Each Preliminary
Prospectus, if any, at the time of filing thereof, and the General Disclosure
Package, at the Applicable Time, conformed in all material respects to the
requirements of the Securities Act and the Rules and Regulations, and did not
contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided,
however, that the Company makes no representations or warranties as to information
contained in or omitted from any Preliminary Prospectus or the General Discount
Package in reliance upon, and in conformity with, written information furnished to
the Company by the Placement Agents through the Representative specifically for
inclusion therein, which information the parties hereto agree is limited to the
Placement Agents’ Information (as defined in Section 16 hereof).

	 	(d)	 	At the time the Registration Statement and any amendments thereto became
effective, at the date of this Agreement and at the Closing Date, the Registration
Statement and any amendments thereto conformed and will conform in all material
respects to the requirements of the Securities Act and the Rules and Regulations and
did not and will not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements
therein not misleading; and the Pricing Prospectus and Prospectus and any amendments or
supplements thereto, at time the Pricing Prospectus and Prospectus or any amendment or
supplement thereto was issued and at the Closing Date, conformed and will conform in
all material respects to the requirements of the Securities Act and the Rules and
Regulations and did not and will not contain an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading;
provided, however, that the foregoing representations and warranties in
this Section 2(d) shall not apply to information contained in or omitted from
the Registration Statement or the Pricing Prospectus and Prospectus, or any amendment
or supplement thereto, in reliance upon, and in conformity with, written information
furnished to the Company by the Placement Agents through the Representative
specifically for inclusion therein, which information the parties hereto agree is
limited to the Placement Agents’ Information (as defined in Section 16 hereof).
	 
	 	(e)	 	Each Issuer Free Writing Prospectus, if any, as of its issue date and at all
subsequent times through the completion of the public offer and sale of the Shares or
until any earlier date that the Company notified or notifies the Placement Agents as
described in Section 4(e) hereof, did not, does not and will not include any
information that conflicted, conflicts or will conflict with the information contained
in the Registration Statement, Pricing Prospectus or the Prospectus, including any
document incorporated by reference therein and any prospectus supplement deemed to be a
part thereof that has not been superseded or modified, or included or would include an
untrue statement of a material fact or omitted or would omit to

5

 

	 	 	 	state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances prevailing at the
subsequent time, not misleading. The foregoing sentence does not apply to statements
in or omissions from any Issuer Free Writing Prospectus in reliance upon, and in
conformity with, written information furnished to the Company by the Placement
Agents through the Representative specifically for inclusion therein, which
information the parties hereto agree is limited to the Placement Agents’ Information
(as defined in Section 16 hereof).

	 	(f)	 	The documents incorporated by reference in the Registration Statement, the
Pricing Prospectus and the Prospectus, when they became effective or were filed with
the Commission, as the case may be, conformed in all material respects to the
requirements of the Securities Act or the Exchange Act, as applicable, and the rules
and regulations of the Commission thereunder and none of such documents contained any
untrue statement of a material fact or omitted to state any material fact required to
be stated therein or necessary to make the statements therein not misleading; and any
further documents so filed and incorporated by reference in the Registration Statement,
the Pricing Prospectus and the Prospectus, when such documents become effective or are
filed with the Commission , as the case may be, will conform in all material respects
to the requirements of the Securities Act or the Exchange Act, as applicable, and the
rules and regulations of the Commission thereunder and will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading.
	 
	 	(g)	 	The Company has not, directly or indirectly, distributed and will not
distribute any offering material in connection with the offering and sale of the Shares
other than any Preliminary Prospectus, the Pricing Prospectus and the Prospectus and
other materials, if any, permitted under the Securities Act and consistent with
Section 4(b) hereof. The Company will file with the Commission all Issuer Free
Writing Prospectuses, if any, in the time and manner required under Rules 164(b)(2) and
433(d) under the Securities Act.
	 
	 	(h)	 	(i) The Company has been duly incorporated and is validly existing as a
corporation in good standing under the Laws of the State of Colorado, and (ii) each of
the subsidiaries of the Company, as listed on Schedule IV hereto (collectively,
the “Subsidiaries”), has been duly incorporated and is validly existing as a
corporation in good standing under the Laws of the jurisdiction of its incorporation.
The Company and each of the Subsidiaries have all requisite corporate power and
authority and all necessary authorizations, consents, approvals, orders, licenses
(including, without limitation, insurance licenses), grants, exemptions, certificates,
qualifications, registrations, franchises and permits (collectively, “Approvals”) of
and from every federal, state, local or foreign court or tribunal or governmental
agency or regulatory or other body or commission, (including, without limitation,
self-regulating organizations and insurance regulatory agencies) having jurisdiction
over the Company or any of the Subsidiaries or any of their assets or properties
(including, without limitation, the New York Stock Exchange (the “NYSE”))

6

 

	 	 	 	(each, a “Governmental Entity”) to own their assets and properties and to conduct
their businesses as disclosed in the General Disclosure Package. All such Approvals
are in full force and effect, and the Company is not in default under any such
Approval, except to the extent the failure of such Approval to be in full force and
effect or to be in default would not, individually or in the aggregate, reasonable
be expected to have a Material Adverse Effect. All of the Approvals necessary or
appropriate for the Company to enter into this Agreement and the Subscription
Agreements and to carry out the provisions and conditions hereof and thereof and the
transactions contemplated hereby and thereby are in full force and effect. The
Company and each of the Subsidiaries: (x) are duly qualified to transact business in
all jurisdictions in which such qualification is necessary or appropriate in
connection with the conduct of their business; (y) own, or possess adequate rights
to use, all patents, trademarks, service marks, copyrights, trademarks, trade
secrets and rights necessary or advisable for the conduct of their businesses as
disclosed in the General Disclosure Package and none of them has received any notice
and is not otherwise aware of any conflict with the asserted rights of others, and
the Company knows no basis therefor; and (z) conduct their respective businesses in
compliance, in all material respects, with all applicable federal, state, local and
foreign statutes, laws, rules, regulations, decisions, judgments, directives,
decrees and orders (collectively, “Laws”). Since January 1, 2001, neither the
Company nor any of the Subsidiaries has received any formal communication from any
Governmental Entity asserting that the Company or any of the Subsidiaries is not in
compliance, in all material respects, with any Approval or any applicable Law.

	 	(i)	 	The Subsidiaries are the only subsidiaries, direct or indirect, of the Company
which are material to the Company’s business. The outstanding shares of capital stock
of each of the Subsidiaries that is a corporation have been duly authorized and validly
issued, are fully paid and nonassessable, and, to the extent set forth in Schedule
IV hereto, are owned by the Company or another Subsidiary free and clear of all
liens, encumbrances and equities and claims; and no options, warrants or other rights
to purchase, agreements or other obligations to issue or other rights to convert any
obligations into or exercise or exchange for shares of capital stock or other ownership
interests in the Subsidiaries are outstanding.
	 
	 	(j)	 	Each Subsidiary that is required to be organized or licensed as an insurance
company (each, an “Insurance Subsidiary”) is duly organized and licensed as an
insurance company in each jurisdiction where it is required to be so licensed or
authorized to conduct its business. Except as otherwise disclosed in the General
Disclosure Package, each Insurance Subsidiary has all Approvals of and from all
insurance Governmental Entities (collectively, “Insurance Authorities”) to conduct its
business, with such exceptions as would not, individually or in the aggregate,
reasonably be expected to (i) have a material adverse effect on (A) the business,
properties, assets, current or future consolidated financial position, reserves,
surplus, business prospects, shareholders’ equity or results of operations of the
Company and the Subsidiaries, taken as a whole, (B) the Company’s liability for future
policy benefits, policyholder account balances and other claims, or (C) the ability of
the Company to sell the Shares to the Purchasers in accordance with

7

 

	 	 	 	this Subscription Agreements or otherwise comply with, perform its obligations under
or consummate the transactions contemplated by this Agreements or the Subscription
Agreements, or (ii) result in the delisting of the Common Stock from the NYSE (a
“Material Adverse Effect”). There is no pending or, to the knowledge of the
Company, threatened action, suit, investigation or proceeding before or by any
Governmental Entity (each, a “Proceeding”) that could reasonably be expected to lead
to the revocation, termination or suspension of any Approval. To the knowledge of
the Company, no Insurance Authority has issued any order or decree impairing,
restricting or prohibiting the payment of dividends by any Insurance Subsidiary to
its parent. Each of the Company and each Insurance Subsidiary has made all filings,
registrations and declarations (collectively, “Filings”) with all Insurance
Authorities necessary to own, lease, license and use its assets and properties and
to conduct its business in the manner described in the General Disclosure Package.
Each Insurance Subsidiary is in compliance with, and conducts its businesses in
conformity with, in all material respects, all applicable Laws.

	 	(k)	 	All reinsurance treaties and similar arrangements (including placement slips)
to which any Insurance Subsidiary is a party are in full force and effect and no
Insurance Subsidiary is in violation of, or in default in the performance, observance
or fulfillment of, any obligation, agreement, covenant or condition contained therein,
except for such violation or default which would not individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect; no Insurance Subsidiary has
received any notice from any of the other parties to such treaties or arrangements that
such other party intends not to perform such treaty or arrangement and, to the
knowledge of the Company and each Insurance Subsidiary, none of the other parties to
such treaties or arrangements will be unable to perform such treaty or arrangement
except (i) to the extent adequately and properly reserved for in the audited historical
financial statements of the Company included in the Registration Statement and the
General Disclosure Package or (ii) to the extent that such nonperformance would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect; and except as disclosed in the General Disclosure Package, no Insurance
Subsidiary has received any notice from any of the other parties to such treaties or
arrangements that such other party intends to terminate such treaty or arrangements.
	 
	 	(l)	 	Except as disclosed in the General Disclosure Package, the Company and its
Insurance Subsidiaries have made no material change in their insurance reserving
practices since December 31, 2005.
	 
	 	(m)	 	The reserves reflected on the statutory statements of each Insurance
Subsidiary, as of the dates specified in such statements, (i) were computed in
accordance with presently accepted actuarial standards consistently applied and are
fairly stated, in accordance with sound actuarial principles, (ii) met the requirements
of all applicable insurance Laws, and are at least as great as the minimum aggregate
amounts required by applicable Law, and (iii) included provision for all actuarial
reserves and related statement items which should be established.

8

 

	 	(n)	 	The statutory financial statements of the Insurance Subsidiaries are prepared
for each relevant period in conformity with applicable statutory accounting principles
or practices required or permitted by applicable Law and by the appropriate insurance
department of the jurisdiction of domicile of each Insurance Subsidiary, respectively,
and such statutory accounting practices have been applied on a consistent basis
throughout the periods involved, except as may otherwise be indicated therein or in the
notes thereto, and present fairly in all material respects the statutory financial
position of each Insurance Subsidiary as of the dates thereof, and the statutory basis
results of operations of each Insurance Subsidiary for the periods covered thereby.
	 
	 	(o)	 	No insurance agent or producer appointed by any Insurance Subsidiary has ceased
selling insurance policies on behalf of such Insurance Subsidiary or has indicated an
interest in decreasing or ceasing the amount of insurance it sells on behalf of such
Insurance Subsidiary or otherwise modifying its relationship with the Company or the
Insurance Subsidiaries, other than (i) in the ordinary course of business consistent
with past practices or (ii) that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
	 
	 	(p)	 	The Company and the Subsidiaries have good and marketable title in fee simple
to, or valid and enforceable leasehold estates in, all items of real and personal
property which are stated in the General Disclosure Package to be owned or leased by
them, in each case free and clear of all liens, encumbrances, claims, security
interests and defects, other than those which are referred to in the General Disclosure
Package, and other than those which would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.
	 
	 	(q)	 	Except as otherwise disclosed in the General Disclosure Package, there is no
Proceeding now pending or, to the knowledge of the Company, threatened or contemplated
by any Governmental Entity or by any other person to which the Company or any of the
Subsidiaries is or is threatened to be made a party or of which any asset or property
of the Company or any of the Subsidiaries is or is threatened to be made the subject,
(i) that is required to be disclosed in the General Disclosure Package by the Act or by
the Regulations and is not disclosed therein or (ii) which, if determined adversely to
the Company or any of the Subsidiaries, would be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect; all pending Proceedings to
which the Company or any of the Subsidiaries is a party or of which any of their assets
or property is the subject, either individually or in the aggregate, which are not
described in the General Disclosure Package, including ordinary routine litigation
incidental to their respective businesses, would not be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect.
	 
	 	(r)	 	Except as otherwise disclosed in the notes thereto or the reports thereon, the
consolidated financial statements and related schedules of the Company and the
Subsidiaries filed with the Commission as part of the Registration Statement and the
General Disclosure Package fairly present the consolidated financial position

9

 

	 	 	 	and the consolidated results of operations of the Company and the Subsidiaries at
the respective dates and for the respective periods to which they apply; such
financial statements and related schedules have been prepared in conformity with
generally accepted accounting principles as applied in the United States (“GAAP”),
consistently applied throughout the periods involved; and all adjustments necessary
for a fair presentation of results for such periods have been made. The summary
financial and statistical data included or incorporated by reference in the
Registration Statement and the General Disclosure Package present fairly the
information shown therein and such data have been compiled on a basis consistent
with the financial statements presented therein and the books and records of the
Company.

	 	(s)	 	Ernst & Young LLP, who have audited certain financial statements of the Company
and the Subsidiaries, are, to the knowledge of the Company, an independent registered
public accounting firm as required by the Act and the Regulations and in accordance
with the requirements of applicable insurance Laws and the published standards of the
National Association of Insurance Commissioners, and, to the knowledge of the Company,
such accountants are not in violation of the auditor independence requirements of the
Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) with respect to the Company.
	 
	 	(t)	 	KPMG LLP, who have audited certain financial statements of the Company and the
Subsidiaries, are, to the knowledge of the Company, independent registered public
accountants as required by the Act and the Regulations and in accordance with the
requirements of applicable insurance Laws and the published standards of the National
Association of Insurance Commissioners, and, to the knowledge of the Company, such
accountants are not in violation of the auditor independence requirements of the
Sarbanes-Oxley Act with respect to the Company.
	 
	 	(u)	 	The business, assets, properties, consolidated financial position, business
prospects, shareholders’ equity and results of operations of the Company and the
Subsidiaries taken as a whole conform to the descriptions thereof contained in the
Registration Statement, the General Disclosure Package and the Final Prospectus.
	 
	 	(v)	 	No default exists, and no event has occurred which, with notice or lapse of
time, or both, would constitute a default or result in an acceleration in the due
performance and observance of any term, covenant or condition of any indenture,
mortgage, deed of trust, note, bank loan or credit agreement or any other material
agreement, understanding or instrument to which the Company or any of the Subsidiaries
is a party or by which any of them or any of their respective assets or properties may
be bound or affected (including, without limitation, any agreement or instrument filed
as an exhibit to the Registration Statement or any Incorporated Document), except for
any such breaches or defaults which, individually or in the aggregate, would not
reasonably be expected to have a Material Adverse Effect.
	 
	 	(w)	 	(i) The Company is not in violation of any term or provision of its Restated
and Amended Articles of Incorporation or Bylaws, and (ii) none of the Subsidiaries is

10

 

	 	 	 	in violation of any term or provision of its certificate or articles of
incorporation or its bylaws, as applicable.

	 	(x)	 	Neither the execution and delivery by the Company of this Agreement, the
consummation by the Company of the transactions contemplated hereby nor the compliance
by the Company with the terms and provisions hereof will (i) conflict with, result in a
breach of, or acceleration under, or constitute a default under any of the terms,
provisions or conditions of, (A) the Restated and Amended Articles of Incorporation or
the Bylaws of the Company or the certificate or articles of incorporation or its
bylaws, as applicable, of any of the Subsidiaries or (B) any material agreement or
instrument to which any of them is a party or by which any of them or any of their
assets is or are bound (including, without limitation, any agreement or instrument
filed as an exhibit to the Registration Statement or any Incorporated Document) or (ii)
violate any Approval or Law.
	 
	 	(y)	 	The Company has authorized, issued and outstanding capital stock, including
preferred stock, as set forth in the General Disclosure Package. All of the issued
shares of the Common Stock are duly and validly authorized, issued and outstanding,
fully paid and nonassessable, and free of preemptive rights, and the Shares, when
issued and delivered in accordance with this Agreement, will be duly and validly
authorized, issued and outstanding, fully paid and nonassessable, and free of
preemptive rights. The Common Stock and the other securities of the Company conform to
all statements in relation thereto contained in the General Disclosure Package. All of
the issued shares of Common Stock and preferred stock of the Company have been issued
in compliance with all applicable federal and state securities Laws, including all
applicable insurance securities Laws.
	 
	 	(z)	 	The Company has obtained from each of its executive officers and directors an
executed lock-up agreement in substantially the form of Exhibit B hereto.
	 
	 	(aa)	 	Except as disclosed in the General Disclosure Package, there are no contracts,
agreements or understandings between the Company and any person granting such person
the right to require the Company to file a registration statement under the Act with
respect to any securities of the Company owned or to be owned by such person or to
require the Company to include such securities in the securities registered pursuant to
the Registration Statement or in any securities being registered pursuant to any other
registration statement filed by the Company under the Act (collectively, “registration
rights”), and any person to whom the Company has granted registration rights has agreed
not to exercise such rights until after the expiration of the period (the “Lock-Up
Period”) described below. The initial Lock-Up Period will commence on the date of the
Final Prospectus and will end 90 days after such date, or such earlier date that the
Representative consents to in writing; provided, however, that if (i)
during the last 17 calendar days of such 90-day period, the Company issues a earnings
release or material news or a material event relating to the Company occurs, or (ii)
prior to the expiration of such 90-day period, the Company announces that it will
release earnings results during the 16 calendar-day period beginning on the last day of
such 90-day period, then, in each

11

 

	 	 	 	case, such 90-day period shall be extended until the expiration of the 18
calendar-day period that begins on the date of the issuance of any such release or
on which such material news or material event occurs, as applicable, unless the
Representative waives, in writing, such extension. The Company will provide the
Representative with notice of any announcement described in the preceding clause
(ii) that gives rise to an extension of such 90-day period.

	 	(bb)	 	This Agreement has been duly and validly authorized, executed and delivered by
the Company.
	 
	 	(cc)	 	Neither the Company nor any of the Subsidiaries has sustained, since the end of
the period covered by the latest audited financial statements included in the General
Disclosure Package, any Material Adverse Effect or any material loss or interference
with its business from fire, explosion, accident, hurricane, earthquake, theft,
sabotage, flood or other calamity or malicious act, whether or not covered by
insurance, or from any labor dispute or action, order or decree of any Governmental
Entity, other than as set forth in the General Disclosure Package. Since the date as
of which information is given in the General Disclosure Package, there has not been any
change in the capitalization or indebtedness for borrowed money of the Company or any
of the Subsidiaries, and no event or development has occurred that individually or in
the aggregate has had, or would be reasonably expected to have, a Material Adverse
Effect. Other than as disclosed or otherwise reflected in the General Disclosure
Package, there have been no transactions entered into by the Company or any of the
Subsidiaries, other than those in the ordinary course of business, which are material
with respect to the Company and the Subsidiaries, taken as a whole, and there has been
no dividend or distribution of any kind declared, paid or made by the Company on any
class of its capital stock.
	 
	 	(dd)	 	No Subsidiary of the Company is currently prohibited, directly or indirectly,
under any agreement or other instrument to which it is a party or is subject, from
paying any dividends to the Company or any other Subsidiary, from making any other
distribution on such Subsidiary’s capital stock or from repaying to the Company any
loans or advances to such Subsidiary from the Company or another Subsidiary, other than
as disclosed in the General Disclosure Package.
	 
	 	(ee)	 	The Company and the Subsidiaries have filed all federal, state, local and
foreign tax returns which are required to be filed by each of them or have requested
extensions thereof and have paid all taxes shown on such returns and all assessments
received by any of them to the extent that the same have become due. All tax
liabilities have been adequately provided for in the financial statements of the
Company, and the Company does not know of any actual or proposed additional material
tax assessments except as disclosed in the General Disclosure Package.
	 
	 	(ff)	 	Except for (i) the supplemental listing application to be filed by the Company
with the NYSE to list the Shares and (ii) permits and similar authorizations required
under the securities or Blue Sky Laws of certain jurisdictions, no consent,
authorization, or approval is required from any Governmental Entity in connection

12

 

	 	 	 	with this Agreement and the transactions contemplated hereby, other than such
consents, authorizations or approvals that have been obtained.

	 	(gg)	 	Neither the Company nor any of the Subsidiaries, nor any officer or director of
any of them nor, to the knowledge of the Company, any employee of any of them, has made
any payment of funds of the Company or any of the Subsidiaries or purchased any
property with funds of the Company or any of the Subsidiaries in a manner prohibited by
Law, and no funds of the Company or any of the Subsidiaries or property purchased with
funds of the Company or any of the Subsidiaries have been set aside to be used for any
payment prohibited by applicable Law. Neither the Company nor any of the Subsidiaries
nor, to the knowledge of the Company, any employee or agent of the Company or any
Subsidiary in his/her capacity as such, has made any contribution or other payment to
any official of, or candidate for, any federal, state or foreign office in violation of
any applicable Law.
	 
	 	(hh)	 	The Company is subject to the reporting requirements of Section 13 of the
Exchange Act and files reports with the Commission on the EDGAR System. The Common
Stock (including the Shares) is registered pursuant to Section 12(b) of the Exchange
Act and is listed on the NYSE. The Company has taken no action designed to, or
reasonably likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act or delisting the Common Stock from the NYSE, nor has the
Company received any notification that the Commission or the NYSE is contemplating
terminating such registration or listing. The Shares are duly listed, and admitted and
authorized for trading, subject to official notice of issuance, on the NYSE.
	 
	 	(ii)	 	Neither the Company nor any of the Subsidiaries nor any affiliate of any of
them has taken, and they will not take, directly or indirectly, any action designed to
cause or result in, or which has constituted or which might reasonably be expected to
constitute, the stabilization or manipulation of the price of the Common Stock in order
to facilitate the sale or resale of the Shares. The Company acknowledges that the
Placement Agents may engage in passive market-making transactions in the Common Stock
in accordance with Regulation M promulgated under the Exchange Act.
	 
	 	(jj)	 	Except for the Subsidiaries and affiliates as disclosed on Schedule III
hereto, neither the Company nor any of the Subsidiaries owns any shares of capital
stock or any equity securities of any corporation or entity (other than shares of
equity securities held as investments in the Company’s reserves).
	 
	 	(kk)	 	Since January 1, 2004, the Company has filed all reports, proxy statements and
other information, and all amendments to previously filed reports, proxy statements and
other information, required to be filed by it pursuant to Sections 13, 14 or 15(d) of
the Exchange Act.
	 
	 	(ll)	 	The Company is not, and after giving effect to the use of the proceeds from the
offering contemplated hereby will not be, an “investment company,” or a company

13

 

	 	 	 	“controlled” by an “investment company,” within the meaning of the Investment
Company Act of 1940, as amended (the “1940 Act”).

	 	(mm)	 	(i) Each of the Company and each of its Subsidiaries maintains a system of
internal accounting controls sufficient to provide reasonable assurances that (w)
transactions are executed in accordance with management’s general or specific
authorization; (x) transactions are recorded as necessary to permit preparation of
financial statements in conformity with GAAP and to maintain accountability for assets;
(y) access to material assets is permitted only in accordance with management’s general
or specific authorization; and (z) the recorded accountability for assets is compared
with existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.

	 
	 		 	(ii) Since the date of the filing of the Company’s Quarterly Report on Form 10-Q for
the quarter ended September 30, 2007, neither the Company’s auditors nor the Audit
Committee of the Company have been advised of (x) any significant deficiencies in
the design or operation of internal controls which could adversely affect the
Company’s ability to record, process, summarize and report financial data nor any
material weaknesses in internal controls or (y) any fraud, whether or not material,
involving management or other employees who have a significant role in the Company’s
internal controls.

	 
	 	(nn)	 	Each of the Company and each of its Subsidiaries carries, or is covered by,
insurance provided by insurers of recognized financial responsibility in such amounts
and covering such losses and risks as it believes is prudent and adequate for the
conduct of its business and the value of its property, and neither the Company nor any
of the Subsidiaries has any reason to believe that any of them will not be able to
renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business.
The Company has never maintained, and does not currently maintain, a directors’ and
officers’ liability insurance policy.
	 
	 	(oo)	 	Each of the members of each of the Audit Committee and the Compensation
Committee of the Board of Directors of the Company is an “independent director” within
the meaning of the listing standards and rules of the NYSE and, with respect to the
Audit Committee, the Commission. Each of the members of the Audit Committee is
financially literate within the meaning of the listing standards and rules of the NYSE,
and at least one member of the Audit Committee is an “audit committee financial expert”
within the meaning of Item 401(h) of Regulation S-K promulgated by the Commission.
	 
	 	(pp)	 	The Company and each Subsidiary, and each of their respective “pension plans”
(as defined in the Employee Retirement Income Security Act of 1974, as amended,
including the regulations and published interpretations thereunder (“ERISA”)), are in
compliance in all material respects with all currently applicable provisions of ERISA.
No “reportable event” (as defined in ERISA) has occurred with respect to any pension
plan for which the Company or any Subsidiary would have any

14

 

	 	 	 	liability. Neither the Company nor any of its Subsidiaries has incurred, and
neither the Company nor any of its Subsidiaries expects to incur, liability under
(i) Title IV of ERISA with respect to termination of, or withdrawal from, any
pension plan or (ii) Sections 412 or 4971 of the Internal Revenue Code of 1986, as
amended, including the regulations and published interpretations thereunder (the
“Code”); and each pension plan for which the Company or any Subsidiary would have
any liability that is intended to be qualified under Section 401(a) of the Code is
so qualified in all material respects and nothing has occurred, whether by action or
by failure to act, which would cause the loss of such qualification.

	 	(qq)	 	(i) The Company has established and maintains disclosure controls and
procedures (as such term is defined in Rule 13a-14 under the Exchange Act); (ii) such
disclosure controls and procedures are designed so that information required to be
disclosed by the Company in the reports it files or submits under the Exchange Act is
accumulated and communicated to the Company’s management, including its principal
executive officer and its principal financial officer, as appropriate, to allow timely
decisions regarding disclosure; and (iii) such disclosure controls and procedures are
effective in all material respects to perform the functions for which they were
established.
	 
	 	(rr)	 	The chief executive officer and the chief financial officer of the Company have
made all certifications required by the Sarbanes-Oxley Act and any related rules and
regulations promulgated by the Commission, and the statements contained in any such
certification are complete and correct. The Company is in compliance with the
provisions of the Sarbanes-Oxley Act and the related rules and regulations promulgated
by the Commission applicable to the Company and will comply with those provisions of
the Sarbanes-Oxley Act that will become effective in the future upon their
effectiveness.
	 
	 	(ss)	 	Except as disclosed in the General Disclosure Package, there are no contracts,
agreements or understandings between the Company and any person that would give rise to
a valid claim against the Company, or any Placement Agent, for a brokerage commission,
finder’s fee or other such payment.
	 
	 	(tt)	 	No forward-looking statement (within the meaning of Section 27A of the Act and
Section 21E of the Exchange Act) contained in the Registration Statement, any
Preliminary Prospectus, the General Disclosure Package or any Prospectus has been made
or reaffirmed by the Company without a reasonable basis or has been disclosed by the
Company other than in good faith.
	 
	 	(uu)	 	(i) At the earliest of time after the filing of the Registration Statement that
the Company or another offering participant made a bona fide offer (within the meaning
of Rule 164(h)(2) of the Regulations) of the Shares and (ii) at the date of this
Agreement, the Company was not and is not an “ineligible issuer,” as defined in Rule
405 of the Regulations.

15

 

     Any certificate signed by an officer of the Company and delivered to you or to counsel for the
Placement Agents at the Closing Date shall be deemed to be a representation and warranty by the
Company to each Placement Agent as to the matters set forth therein.

3. The Closing. The time and date of closing and delivery of the documents required to be
delivered to the Placement Agents pursuant to Section 6 hereof shall be at 10:00 A.M.,
local time, on December 4, 2007 (the “Closing Date”) at the offices of Kramer Levin Naftalis &
Frankel LLP, 1177 Avenue of the Americas, 29th Floor, New York, New York 10036.

4. Further Agreements of the Company. The Company agrees with the Placement Agents:

	 	(a)	 	(i) To prepare the Prospectus in a form approved by the Placement Agent
containing information previously omitted at the time of effectiveness of the
Registration Statement in reliance on Rules 430A, 430B and 430C of the Rules and
Regulations and to file such Prospectus pursuant to Rule 424(b) of the Rules and
Regulations not later than the second business (2nd) day following the
execution and delivery of this Agreement or, if applicable, such earlier time as may be
required by Rule 430A of the Rules and Regulations; (ii) to notify the Placement Agents
immediately of the Company’s intention to file or prepare any supplement or amendment
to the Registration Statement, the General Disclosure Package or to the Prospectus;
(iii) to make no further amendment or supplement prior to the Closing Date to the
Registration Statement or any amendment or supplement to the General Disclosure Package
or Prospectus without the consent of the Representative, which consent shall not be
unreasonably delayed or withheld; (iv) for so long as the delivery of a prospectus is
required in connection with the offering or sale of the Shares to advise the
Representative, promptly after it receives notice thereof, of the time when any
amendment to the Registration Statement has been filed or becomes effective or any
amendment or supplement to the General Disclosure Package or Prospectus has been filed
and to furnish the Representative with copies thereof; (v) to file on a timely basis
all reports and any definitive proxy or information statements required to be filed by
the Company with the Commission and the NYSE pursuant to Section 13(a), 15 or 15(d) of
the Exchange Act subsequent to the date of the Prospectus and for so long as the
delivery of a prospectus is required in connection with the offering or sale of the
Shares; (vi) to advise the Representative, promptly after the Company receives notices
thereof, of (x) any request by the Commission to amend the Registration Statement or to
amend or supplement the General Disclosure Package or Prospectus or for additional
information and (y) the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or any post-effective amendment thereto or
any order directed at any Incorporated Document or any amendment or supplement thereto
or any order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus, of the suspension of the qualification of
the Shares for offering or sale in any jurisdiction, of the institution or threatening
of any proceeding for any such purpose, or of any request by the Commission that the
Company amend or supplement the Registration Statement, the General Disclosure Package
or the Prospectus or for additional information; and (vii) in the event of

16

 

	 	 	 	the issuance of any stop order or of any order preventing or suspending the use of
any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or
suspending any such qualification, and promptly to use its best efforts to obtain
the withdrawal of such order.

	 	(b)	 	The Company represents and agrees that, unless it obtains the prior consent of
the Representative, and the Representative represents and agrees that, unless it
obtains the prior consent of the Company, it has not made and will not, make any offer
relating to the Shares that would constitute a “free writing prospectus” as defined in
Rule 405 under the Securities Act unless the prior written consent of the
Representative or the Company, respectively, has been received (each, a “Permitted Free
Writing Prospectus”); provided that the prior written consent of the Representative
hereto shall be deemed to have been given in respect of the Issuer Free Writing
Prospectus(es), if any, included in Schedule III hereto. The Company represents
that it has treated and agrees that it will treat each Permitted Free Writing
Prospectus created by the Company as an Issuer Free Writing Prospectus, comply with the
requirements of Rules 164 and 433 under the Securities Act applicable to any Issuer
Free Writing Prospectus, including the requirements relating to timely filing with the
Commission, legending and record keeping and will not take any action that would result
in the Placement Agents or the Company being required to file with the Commission
pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by
or on behalf of such Placement Agents that such Placement Agents otherwise would not
have been required to file thereunder.
	 
	 	(c)	 	If at any time when the Prospectus relating to the Shares is required to be
delivered (or in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act) any event occurs or condition exists as a result of which the
Prospectus as then amended or supplemented would include any untrue statement of a
material fact, or omit to state any material fact necessary to make the statements
therein, in light of the circumstances under which they were made when the Prospectus
is delivered (or in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act), not misleading, or if it is necessary at any time to amend or
supplement any Registration Statement or the Prospectus or to file under the Exchange
Act any document incorporated by reference in the Prospectus, to comply with the
Securities Act or the Exchange Act, that the Company will promptly notify the Placement
Agents thereof and upon their request will prepare an appropriate amendment or
supplement or upon their request make an appropriate filing pursuant to Section 13 or
14 of the Exchange Act in form and substance reasonably satisfactory to the Placement
Agents which will correct such statement or omission or effect such compliance and will
use its best efforts to have any amendment to any Registration Statement declared
effective as soon as possible. The Company will furnish without charge to each
Placement Agent and to any dealer in securities as many copies as such Placement Agent
may from time to time reasonably request of such amendment or supplement.

17

 

	 	(d)	 	If the General Disclosure Package is being used to solicit offers to buy the
Shares at a time when the Prospectus is not yet available to prospective purchasers and
any event shall occur as a result of which, in the judgment of the Company or in the
reasonable opinion of the Representative, it becomes necessary to amend or supplement
the General Disclosure Package in order to make the statements therein, in the light of
the circumstances then prevailing, not misleading, or to make the statements therein
not conflict with the information contained or incorporated by reference in the
Registration Statement then on file with the Commission and not superseded or modified,
or if it is necessary at any time to amend or supplement the General Disclosure Package
to comply with any law, the Company promptly will either (i) prepare, file with the
Commission (if required) and furnish to the Placement Agents and any dealers an
appropriate amendment or supplement to the General Disclosure Package or (ii) prepare
and file with the Commission an appropriate filing under the Exchange Act which shall
be incorporated by reference in the General Disclosure Package so that the General
Disclosure Package as so amended or supplemented will not, in the light of the
circumstances then prevailing, be misleading or conflict with the Registration
Statement then on file, or so that the General Disclosure Package will comply with law.
The foregoing sentence does not apply to statements in or omissions from the General
Disclosure Package in reliance upon, and in conformity with, written information
furnished to the Company by the Placement Agents through this Representative
specifically for inclusion therein, which information the parties hereto agree is
limited to the Placement Agents’ Information (as defined in Section 16 hereof).
	 
	 	(e)	 	If at any time following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or will conflict with the information contained in the
Registration Statement, Pricing Prospectus or Prospectus, including any document
incorporated by reference therein, and any prospectus supplement deemed to be a part
thereof and not superseded or modified or included or would include an untrue statement
of a material fact or omitted or would omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of
the circumstances prevailing at the subsequent time, not misleading, the Company has
promptly notified or will promptly notify the Placement Agent so that any use of the
Issuer Free Writing Prospectus may cease until it is amended or supplemented and has
promptly amended or will promptly amend or supplement, at its own expense, such Issuer
Free Writing Prospectus to eliminate or correct such conflict, untrue statement or
omission. The foregoing sentence does not apply to statements in or omissions from any
Issuer Free Writing Prospectus in reliance upon, and in conformity with, written
information furnished to the Company by the Placement Agents through the Representative
specifically for inclusion therein, which information the parties hereto agree is
limited to the Placement Agents’ Information (as defined in Section 16 hereof).
	 
	 	(f)	 	To deliver promptly to the Representative such number of the following
documents as the Representative shall reasonably request: (i) conformed copies of the
Registration Statement as originally filed with the Commission (in each case

18

 

	 	 	 	excluding exhibits), (ii) each Preliminary Prospectus, if any, (iii) any Issuer Free
Writing Prospectus, (iv) the Prospectus (the delivery of the documents referred to
in clauses (i), (ii), (iii) and (iv) of this Section 4(f) to be made not
later than 10:00 A.M., New York time, on the Business Day following the execution
and delivery of this Agreement), (v) conformed copies of any amendment to the
Registration Statement (excluding exhibits), (vi) any amendment or supplement to the
General Disclosure Package or the Prospectus (the delivery of the documents referred
to in clause (v)  of this Section 4(f) and this clause (vi) to be made not
later than 10:00 A.M., New York City time, on the Business Day following the date of
such amendment or supplement) and (vii) any document incorporated by reference in
the General Disclosure Package or the Prospectus (excluding exhibits thereto) (the
delivery of the documents referred to in clause (vi) of this Section 4(f) to
be made not later than 10:00 A.M., New York City time, on the Business Day following
the date of such document).

	 	(g)	 	To make generally available to its stockholders and the Representative as soon
as practicable, but in any event not later than eighteen months after the effective
date of the Registration Statement (as defined in Rule 158(c) of the Rules and
Regulations), an earnings statement of the Company (which need not be audited)
satisfying Section 11(a) of the Securities Act and the Rules and Regulations
(including, at the option of the Company, Rule 158 of the Rules and Regulations).
	 
	 	(h)	 	To promptly take from time to time such actions as the Representative may
reasonably request to qualify the Shares for offering and sale under the state
securities, or blue sky, laws of such jurisdictions (including without limitation any
post-filing requirements) as the Representative may reasonably designate and to
continue such qualifications in effect for so long as required for the distribution of
the Shares. The Company shall not be obligated to qualify as a foreign corporation in
any jurisdiction in which it is not so qualified or to file a general consent to
service of process in any jurisdiction.
	 
	 	(i)	 	Not to directly or indirectly sell, assign, transfer, pledge, contract to sell
of any shares of Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock for a period of 90 days after the Closing Date without
the prior written consent of the Representative. The Company will cause each of its
(A) executive officers who are listed in the Company’s Form 10-K/A for the year ended
December 31, 2006 and who are employed by the Company as of the date hereof and (B)
directors to furnish to the Representative, prior to the Closing Date, a letter,
substantially in the form of Exhibit B hereto.
	 
	 	(j)	 	Prior to the Closing Date, to furnish to the Placement Agents, as soon as they
have been prepared, copies of any unaudited interim consolidated financial statements
of the Company for any periods subsequent to the periods covered by the financial
statements appearing or incorporated by reference in the General Disclosure Package or
the Registration Statement.

19

 

	 	(k)	 	Prior to the Closing Date, not to issue any press release or other
communication directly or indirectly or hold any press conference with respect to the
Company, its condition, financial or otherwise, or earnings, business affairs or
business prospects (except for routine oral marketing communications or press releases
in the ordinary course of business and consistent with the past practices of the
Company and of which the Representative is notified), without the prior written consent
of the Representative (which shall not be unreasonably withheld or delayed), unless in
the judgment of the Company and its counsel, and after notification to the
Representative, such press release or communication is required by law. In such event,
the Company shall consult with the Representative as to the contents of such press
release.
	 
	 	(l)	 	To engage and maintain, at its expense, a registrar and transfer agent for the
Common Stock.
	 
	 	(m)	 	To supply the Representative with copies of all correspondence to and from, and
all related documents issued to and by, the Commission in connection with the
registration of the Shares under the Securities Act.
	 
	 	(n)	 	The Company will use its best efforts to cause the Shares to be listed on the
NYSE at the Closing Date.

5. Payment of Expenses. The Company agrees with the Placement Agents to pay (a) the costs
incident to the authorization, issuance, sale, preparation and delivery of the Shares to the
Purchasers and any transfer taxes payable in that connection; (b) the costs incident to the
Registration of the Shares under the Securities Act; (c) the costs incident to the preparation,
printing and distribution of the Registration Statement, any Issuer Free Writing Prospectus, the
General Disclosure Package, the Prospectus, any amendments, supplements and exhibits thereto or any
document incorporated by reference therein, and the costs of printing, reproducing and distributing
any transaction document by mail, telex or other means of communications; (d) at the Closing, the
fees and expenses incurred in connection with filings, if any, made with the NASD (including
related reasonable fees and expenses of counsel for the Placement Agents), if applicable; (e) any
other applicable listing or other fees; (f) the fees and expenses of qualifying the Shares under
the securities laws of the several jurisdictions as provided in Section 4(h) hereof and of
preparing a Blue Sky Memorandum (including related reasonable fees and expenses of counsel to the
Placement Agents in respect thereof); (g) all fees and expenses of the registrar and transfer agent
of the Common Stock; and (h) all other costs and expenses incident to the performance of the
obligations of the Company under this Agreement (including, without limitation, the fees and
expenses of the Company’s counsel and the Company’s independent accountants and the travel and
other expenses incurred by Company personnel in connection with any “roadshow” including, without
limitation, any expenses advanced by the Placement Agents on the Company’s behalf and with the
Company’s prior consent (which will be promptly reimbursed)); provided that, except
as otherwise provided in this Section 5 and in Sections 7 and 9 hereof,
each of the Placement Agents shall pay its own respective costs and expenses, including, without
limitation, the fees and disbursements of their counsel.

20

 

6. Conditions to the Obligations of the Placement Agents and the Purchasers, and the Sale of
the Shares. The obligations of the Placement Agents and the closing of the sale of the Shares
hereunder are subject to the accuracy, when made and on the Closing Date, of the representations
and warranties on the part of the Company contained herein, to the accuracy of the statements of
the Company made in any certificates pursuant to the provisions hereof, to the performance by the
Company of its obligations hereunder, and to each of the following additional terms and conditions:

	 	(a)	 	No stop order suspending the effectiveness of the Registration Statement or any
part thereof, preventing or suspending the use of any Base Prospectus, any Preliminary
Prospectus, any Permitted Free Writing Prospectus or the Prospectus or any part thereof
shall have been issued and no proceedings for that purpose or pursuant to Section 8A
under the Securities Act shall have been initiated or threatened by the Commission, and
all requests for additional information on the part of the Commission (to be included
or incorporated by reference in the Registration Statement or the Prospectus or
otherwise) shall have been complied with; and the Rule 462(b) Registration Statement,
if any, each Preliminary Prospectus, each Issuer Free Writing Prospectus and the
Prospectus shall have been filed with, the Commission within the applicable time period
prescribed for such filing by, and in compliance with, the Rules and Regulations and in
accordance with Section 4(a) hereof, and the Rule 462(b) Registration
Statement, if any, shall have become effective immediately upon its filing with the
Commission.
	 
	 	(b)	 	The Placement Agents shall not have discovered and disclosed to the Company on
or prior to the Closing Date that the Registration Statement or any amendment or
supplement thereto contains an untrue statement of a fact which, in the opinion of
counsel for the Placement Agents, is material or omits to state any fact which, in the
opinion of such counsel, is material and is required to be stated therein or is
necessary to make the statements therein not misleading, or that the General Disclosure
Package, any Issuer Free Writing Prospectus or the Prospectus or any amendment or
supplement thereto contains an untrue statement of fact which, in the opinion of such
counsel, is material or omits to state any fact which, in the opinion of such counsel,
is material and is necessary in order to make the statements therein, in the light of
the circumstances in which they were made, not misleading.
	 
	 	(c)	 	All corporate proceedings and other legal matters incident to the
authorization, form, execution, delivery and validity of each of this Agreement, the
Shares, the Registration Statement, the General Disclosure Package, each Issuer Free
Writing Prospectus and the Prospectus and all other legal matters relating to this
Agreement and the transactions contemplated hereby shall be reasonably satisfactory in
all material respects to counsel for the Placement Agents, and the Company shall have
furnished to such counsel all documents and information that it may reasonably request
to enable it to pass upon such matters.
	 
	 	(d)	 	The Placement Agents shall have received from Jones & Keller, P.C., corporate
counsel for the Company such counsel’s written opinion, addressed to the

21

 

	 	 	 	Placement Agents dated as of the Closing Date, in form and substance reasonably
satisfactory to the Representative, as set forth in Exhibit C hereto.

	 	(e)	 	The Placement Agents shall have received from Kramer Levin Naftalis & Frankel
LLP, such opinion, dated the Closing Date and addressed to the Placement Agents, with
respect to the issuance and sale of the Shares, the Registration Statement, the
Prospectus and other related matters as the Placement Agents may reasonably request,
and the Company shall have furnished to such counsel such documents as it requests for
the purpose of enabling it to pass upon such matters.
	 
	 	(f)	 	The Company shall have furnished to the Placement Agents a certificate, dated
the Closing Date, of each of its Chairman and Chief Executive Officer and President
stating that (i) such officers have carefully examined the Registration Statement, the
General Disclosure Package, any Permitted Free Writing Prospectus and the Prospectus
and, in their opinion, the Registration Statement and each amendment thereto, at the
Applicable Time and as of the date of this Agreement and as of the Closing Date did not
include any untrue statement of a material fact and did not omit to state a material
fact required to be stated therein or necessary to make the statements therein not
misleading, and the General Disclosure Package, as of the Applicable Time and as of the
Closing Date, any Permitted Free Writing Prospectus as of its date and as of the
Closing Date, the Prospectus and each amendment or supplement thereto, as of the
respective date thereof and as of the Closing Date, did not include any untrue
statement of a material fact and did not omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances in which they
were made, not misleading, (ii) since the effective date of the Registration Statement
no event has occurred that was required to be disclosed, but was not set forth in, a
supplement or amendment to the Registration Statement, the General Disclosure Package
or the Prospectus, (iii) as of the Closing Date, the representations and warranties of
the Company in this Agreement were true and correct when made and are true and correct
as of the Closing Date in all material respects (or, if any such representations or
warranties are qualified by materiality or Material Adverse Effect, then such
representations and warranties are true and correct in all respects) and the Company
has complied with in all material respects all agreements and covenants contained in
this Agreement and satisfied all conditions on its part to be performed or satisfied
hereunder at or prior to the Closing Date in all material respects, (iv) subsequent to
the date of the most recent financial statements included or incorporated by reference
in the General Disclosure Package, there has been no change, or any event, circumstance
or development involving a prospective change, that would result in a Material Adverse
Effect, except as set forth in the Prospectus or General Disclosure Package, and
(v) the Registration Statement is effective, and to their knowledge, as of the Closing
Date (I) no stop order suspending the effectiveness of the Registration Statement has
been issued and no proceedings for that purpose have been commenced or are pending
before or are contemplated by the Commission and (II) no action has been taken by any
governmental agency, body or official, and no injunction, restraining order or order of
any nature by any federal or state court has been issued, which would prevent the
issuance of the Shares.

22

 

	 	(g)	 	At the time of the execution of this Agreement, the Placement Agents shall have
received from Ernst & Young LLP a letter, addressed to the Placement Agents and dated
such date, in form and substance reasonably satisfactory to the Representative
(i) confirming that they are an independent registered public accounting firm with
respect to the Company within the meaning of the Securities Act and the Rules and
Regulations and (ii) containing the statements and information of the type ordinarily
included in accountant’s “comfort letters” to underwriters, delivered according to
Statement of Auditing Standards No. 72 (or any successor bulletins), with respect to
the financial statements and certain financial information contained or incorporated by
reference in the Registration Statement, the Pricing Prospectus and the Prospectus.
	 
	 	(h)	 	On the Closing Date, the Placement Agents shall have received a letter (the
“bring-down letter”) from Ernst & Young LLP addressed to the Placement Agents, and
dated the Closing Date confirming, as of the date of the bring-down letter (or, with
respect to matters involving changes or developments since the respective dates as of
which specified financial information is given in the Registration Statement, the
Pricing Prospectus and the Prospectus as of a date not more than three Business Days
prior to the date of the bring-down letter), the conclusions and findings of such firm
with respect to the financial information and other matters covered by its letter
delivered to the Placement Agents concurrently with the execution of this Agreement
pursuant to Section 6(g) hereof.
	 
	 	(i)	 	At the time of the execution of this Agreement, the Placement Agents shall have
received from KPMG LLP a letter, addressed to the Placement Agents and dated such date,
in form and substance reasonably satisfactory to the Representative (i) confirming that
they are an independent registered public accounting firm with respect to the Company
within the meaning of the Securities Act and the Rules and Regulations and
(ii) containing the statements and information of the type ordinarily included in
accountant’s “comfort letters” to underwriters, delivered according to Statement of
Auditing Standards No. 72 (or any successor bulletins), with respect to the financial
statements and certain financial information contained or incorporated by reference in
the Registration Statement, the Pricing Prospectus and the Prospectus.
	 
	 	(j)	 	(i) Neither the Company nor any of the Subsidiaries shall have sustained since
the date of the latest audited financial statements included or incorporated by
reference in the Registration Statement, the Pricing Prospectus and the Prospectus any
loss or interference with its business from fire, explosion, flood, terrorist act or
other calamity, whether or not covered by insurance, or from any labor dispute or court
or governmental action, order or decree, otherwise than as set forth in the General
Disclosure Package, and (ii) since such date there shall not have been any change in
the capital stock or long-term debt of the Company or any Subsidiaries or any change,
or any event, circumstances or development involving a prospective change, in or
affecting the business, assets, properties, current or future consolidated financial
position, reserves, surplus, business prospects, shareholders’ equity or results of
operations of the Company and the Subsidiaries, taken as a

23

 

	 	 	 	whole, or the Company’s liability for future policy benefits, policy holder account
balances or other claims, otherwise than as set forth in the General Disclosure
Package, the effect of which, in any such case described in clause (i) or (ii) of
this Section 6(j), is, in the judgment of the Representative, so material
and adverse as to make it impracticable or inadvisable to proceed with the sale or
delivery of the Shares on the terms and in the manner contemplated by the General
Disclosure Package.

	 	(k)	 	The Shares shall be registered under the Exchange Act and, as of the Closing
Date, the Shares shall be listed and admitted and authorized for trading on the NYSE,
and satisfactory evidence of such actions shall have been provided to the
Representative. The Company shall have taken no action with the specific intention of
terminating the registration of the Shares under the Exchange Act or delisting or
suspending from trading the Shares from the NYSE, nor has the Company received any
information suggesting that the Commission or the NYSE is contemplating terminating
such registration or listing.
	 
	 	(l)	 	On the date hereof, the Company shall have furnished to the Representative a
letter substantially in the form of Exhibit B hereto from each executive
officer and each director of the Company.
	 
	 	(m)	 	Subsequent to the execution and delivery of this Agreement, there shall not
have occurred any of the following: (i) trading in securities generally on the New
York Stock Exchange, the Nasdaq Global Market or the American Stock Exchange or in the
over-the-counter market, or trading in any securities of the Company on any exchange or
in the over-the-counter market, shall have been suspended or minimum or maximum prices
or maximum ranges for prices shall have been established on any such exchange or such
market by the Commission, by such exchange or by any other regulatory body or
governmental authority having jurisdiction, (ii) a banking moratorium shall have been
declared by federal or state authorities or a material disruption has occurred in
commercial banking or securities settlement or clearance services in the United States,
(iii) the United States shall have become engaged in hostilities (other than any
current hostilities), or the subject of an act of terrorism, there shall have been a
material escalation in hostilities involving the United States or there shall have been
a declaration of a national emergency or war by the United States or (iv) there shall
have occurred any other calamity or crisis or any change in general economic, political
or financial conditions in the United States or elsewhere, if the effect of any such
event in clause (iii) or (iv) of this Section 6(m) makes it, in the judgment of
the Representative, impracticable or inadvisable to proceed with the sale or delivery
of the Shares on the terms and in the manner contemplated by the General Disclosure
Package.
	 
	 	(n)	 	No action shall have been taken and no statute, rule, regulation or order shall
have been enacted, adopted or issued by any governmental agency or body which would, as
of the Closing Date, prevent the issuance or sale of the Shares or materially and
adversely affect or potentially and adversely affect the business or operations of the
Company; and no injunction, restraining order or order of any other nature by any

24

 

	 	 	 	federal or state court of competent jurisdiction shall have been issued as of the
Closing Date which would prevent the issuance or sale of the Shares or materially
and adversely affect or potentially and adversely affect the business or operations
of the Company.

	 	(o)	 	The Company shall have prepared and filed with the Commission a Current Report
on Form 8-K with respect to the Offering, including as an exhibit thereto this
Agreement and any other documents relating thereto.
	 
	 	(p)	 	The Company shall have entered into Subscription Agreements with each of the
Purchasers and such agreements shall be in full force and effect.
	 
	 	(q)	 	Prior to the Closing Date, the Company shall have furnished to the Placement
Agents such further information, certificates and documents as the Placement Agents may
reasonably request.

     All opinions, letters, evidence and certificates mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Placement Agents.

7. Indemnification and Contribution.

	 	(a)	 	Subject to the conditions set forth below, the Company agrees to indemnify and
hold harmless each Placement Agent, its partners, members, directors, officers and
affiliates, and each other person, if any, who controls each of them within the meaning
of Section 15 of the Act or Section 20(a) of the Exchange Act, against any and all
loss, liability, claim, damage and expense whatsoever (including but not limited to any
and all legal fees and other expense whatsoever reasonably incurred in investigating,
preparing or defending against any litigation or any claim whatsoever) (each, a
“Loss”) arising out of or based upon (i) any untrue statement or alleged untrue
statement of a material fact contained (x) in any part of the Registration Statement at
any time, any Preliminary Prospectus as of any time, the General Disclosure Package as
of the Applicable Time, the Prospectus, any Issuer Free Writing Prospectus or any “road
show” (as defined in Rule 433 of the Regulations) not constituting an Issuer Free
Writing Prospectus (as each from time to time amended and supplemented, as the case may
be), or (y) in any application or other document (in this Section 7
collectively called “application”) executed by the Company or based upon written
information furnished by or on behalf of the Company filed in any jurisdiction in order
to qualify the Shares under the securities Laws thereof or filed with the Commission,
the NYSE or any other securities exchange, or (ii) the omission or alleged omission
therefrom of a material fact required to be stated therein or necessary to make the
statements therein not misleading; provided, however, that the Company
will not be liable in any such case to the extent that any such Loss arises out of or
is based upon an untrue statement or alleged untrue statement or omission or alleged
omission made in any part of the Disclosure Package, the Registration Statement, any
Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or any road
show

25

 

	 	 	 	not constituting an Issuer Free Writing Prospectus, or such amendment or supplement,
in reliance upon and in conformity with written information furnished to the Company
by the Placement Agents through the Representative specifically for inclusion
therein, which information the parties hereto agree is limited to the Placement
Agents’ Information (as defined in Section 16 hereof). This indemnity
agreement will be in addition to any liability which the Company may otherwise have.
If any action or proceeding (including any governmental investigation) is brought
against any Placement Agent or any of its partners, members, directors, officers,
affiliates or controlling persons in respect of which indemnity may be sought
against the Company pursuant to this Section 7(a), such indemnified party
shall promptly notify in writing the party or parties against which indemnification
is to be sought of the institution of such action and the Company shall assume the
defense of such action, including the employment of counsel (satisfactory to the
indemnified party) and payment of expenses. The indemnified party shall have the
right to employ its or their own counsel in any such case, but the fees and expenses
of such counsel shall be at the expense of the indemnified party unless the
employment of such counsel shall have been authorized in writing by the Company in
connection with the defense of such action or the Company shall not have employed
counsel that is satisfactory to the indemnified party to have charge of the defense
of such action, or counsel for such indemnified party or parties shall have
reasonably concluded that there may be defenses available to it or them which are
different from or additional to those available to the Company (in which case the
Company shall not have the right to direct the defense of such action on behalf of
the indemnified party or parties), or that such counsel for the Company would have a
conflict also representing the Placement Agents in the defense of such action, in
any of which events such fees and expenses shall be borne by the Company (it being
understood, however, that the Company shall not, in connection with any one such
action or proceeding, be liable for the fees and expenses of more than one separate
firm of attorneys, together with appropriate local counsel, at any time for all such
indemnified parties, which firm shall be designated in writing by the
Representative). Anything in this Section 7(a) to the contrary
notwithstanding, the Company shall not be liable for any settlement of any such
claim or action effected without its written consent, which consent shall not be
unreasonably withheld or delayed. The Company shall not settle or otherwise
compromise any such claim or action unless as a result thereof, each of the
indemnified parties receives a complete and unconditional release and discharge of
any and all liability with respect to such claim or action in form and substance
satisfactory to such indemnified party. The Company agrees promptly to notify the
Representative of the commencement of any litigation or proceedings against the
Company or any of its officers or directors in connection with the issue and sale of
the Shares or in connection with the Disclosure Package, the Registration Statement,
any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or
any “road show” (as defined in Rule 433 of the Regulations) not constituting an
Issuer Free Writing Prospectus, or any amendment or supplement thereof, or any such
application.

26

 

	 	(b)	 	Each Placement Agent agrees to severally and not jointly indemnify and hold
harmless Company, each of the directors of the Company, each of the officers of the
Company who shall have signed the Registration Statement and each other person, if any,
who controls the Company within the meaning of Section 15 of the Act or Section 20(a)
of the Exchange Act to the same extent as the foregoing indemnity from the Company to
the Placement Agents, but only with respect to statements or omissions, or alleged
statements or omissions, if any, made in the Disclosure Package, the Registration
Statement, any Preliminary Prospectus, the Prospectus or any Issuer Free Writing
Prospectus, or any amendment or supplement thereto, in reliance upon, and in conformity
with, written information furnished to the Company by the Placement Agents through the
Representative specifically for inclusion therein, which information the parties hereto
agree is limited to the Placement Agents’ Information (as defined in Section 16
hereof). In case any action shall be brought against the Company, or any other person
so indemnified, based on the Disclosure Package, the Registration Statement, any
Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus, or any
amendment or supplement thereto, and in respect of which indemnity may be sought
against any Placement Agent, such Placement Agent shall have the rights and duties
given to the Company, and the Company, and each other person so indemnified shall have
the rights and duties given to the Placement Agents, by the provisions of Section
7(a) hereof.
	 
	 	(c)	 	No indemnification provided for in Section 7(a) or 7(b) hereof
shall be available to any party which shall fail to give notice as provided in such
sections if the party to which notice was not given was unaware of the proceeding to
which such notice would have related and was materially prejudiced by the failure to
give such notice, but the failure to give such notice shall not relieve the
indemnifying party or parties from any liability which it or they may have to the
indemnified party for contribution or otherwise than on account of the provisions of
Section 7(a) or 7(b) hereof. Any Losses for which an indemnified party
is entitled to indemnification or contribution under this Section 7 shall be
paid by the indemnifying party to the indemnified party as such Losses are incurred.
	 
	 	(d)	 	If the indemnification provided for in this Section 7 is unavailable to
or insufficient to hold harmless an indemnified party under Section 7(a) or
7(b) hereof in respect of any Losses (or actions in respect thereof) referred
to therein, then each indemnifying party shall contribute to the amount paid or payable
by such indemnified party as a result of such Losses (or actions in respect thereof) in
such proportion as is appropriate to reflect the relative benefits received by the
Company on the one hand and the Placement Agents on the other from the offering of the
Shares. If, however, the allocation provided by the immediately preceding sentence is
not permitted by applicable Law, then each indemnifying party shall contribute to such
amount paid or payable by such indemnified party in such proportion as is appropriate
to reflect not only such relative benefits but also the relative fault of the Company
on the one hand and the Placement Agents on the other in connection with the statements
or omissions which resulted in such Losses (or actions in respect thereof), as well as
any other relevant equitable considerations. The relative

27

 

	 	 	 	benefits received by the Company on the one hand and the Placement Agents on the
other shall be deemed to be in the same proportion as the total net proceeds from
the offering (before deducting expenses) received by the Company bear to the total
fees received by the Placement Agents pursuant to Section 1(e) hereof. The
relative fault shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company on
the one hand or the Placement Agents on the other and the parties’ relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission. The Company and the Placement Agents agree that it would not
be just and equitable if contribution pursuant to this Section 7(d) were
determined by pro rata allocation or by any other method of allocation which does
not take account of the equitable considerations referred to above in this
Section 7(d). The amount paid or payable by an indemnified party as a
result of the Losses (or actions in respect thereof) referred to above in this
Section 7(d) shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating or
defending any such action or claim. Notwithstanding the provisions of this
Section 7(d), the Placement Agent’s obligations to contribute as provided in
this Section 7(d) are several in proportion to the total compensation
received by each of the Placement Agents in accordance with Section 1(e)
hereof and not joint. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Act or Section 10(b) of the Exchange Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentations.

8. Termination. The obligations of the Placement Agents hereunder may be terminated by the
Representative, in its absolute discretion by notice given to the Company prior to delivery
(including electronic delivery) of and payment for the Shares if, prior to that time, any of the
events described in Section 6(m) hereof have occurred or if all of the Purchasers shall
decline to purchase the Shares for any reason permitted under this Agreement or the Subscription
Agreements.

9. Reimbursement of Placement Agents’ Expenses. If this Agreement is terminated pursuant
to any of its provisions, except as otherwise provided in this Agreement, the Company shall not be
under any liability to any Placement Agent (other than for obligations provided for in Section
4 hereof), and no Placement Agent shall be under any liability to the Company;
provided, however, that if this Agreement is terminated by the Representative
because of any failure, refusal or inability on the part of the Company to comply with the terms or
to fulfill any of the conditions of this Agreement, or for any reason provided in Section
6(m) hereof, the Company will reimburse the Placement Agents for all out-of-pocket expenses
(including, without limitation, road show expenses and reasonable fees and disbursements of counsel
to the Placement Agents) incurred by them in connection with the proposed placement of the Shares
or in contemplation of the performance of their obligations hereunder. The Company shall pay, upon
demand, such amount to the Representative, not to exceed $25,000.

     Notwithstanding any election hereunder or any termination of this Agreement, and whether or
not this Agreement is otherwise carried out, the provisions of Section 7 hereof shall not
be in

28

 

any way affected by such election or termination or failure to carry out the terms of this
Agreement or any part hereof.

10. Successors; Persons Entitled to Benefit of Agreement. This Agreement shall inure to
the benefit of and be binding upon each of the Placement Agents and the Company and their
respective successors and permitted assigns. Nothing expressed or mentioned in this Agreement is
intended or shall be construed to give any person other than the persons mentioned in the preceding
sentence any legal or equitable right, remedy or claim under or in respect of this Agreement, or
any provisions herein contained, this Agreement and all conditions and provisions hereof being
intended to be and being for the sole and exclusive benefit of such persons and for the benefit of
no other person; except that the representations, warranties, covenants, agreements and indemnities
(and contribution obligations) of the Company contained in this Agreement, and the indemnities (and
contribution obligations) of the Placement Agents pursuant to Sections 7(b) and (d)
hereof, shall also be for the benefit of the indemnified parties described in Section 7
hereof. It is understood that the Placement Agents’ responsibilities to the Company are solely
contractual in nature and the Placement Agents do not owe the Company, or any other party, any
fiduciary duty as a result of this Agreement.

11. Survival of Indemnities, Representations, Warranties, etc. The respective indemnities,
covenants, agreements, representations, warranties and other statements of the Company and the
Placement Agents, as set forth in this Agreement or made by them pursuant to this Agreement, shall
remain in full force and effect, regardless of any investigation made by or on behalf of the
Placement Agents, the Company or any person controlling any of them and shall survive delivery of
and payment for the Shares.

12. Absence of Fiduciary Relationship. The Company acknowledges and agrees that:

	 	(a)	 	Each Placement Agent’s responsibility to the Company is solely contractual in
nature, the Placement Agents have been retained solely to act as placement agents in
connection with the sale of the Shares and no fiduciary, advisory or agency
relationship between the Company and the Placement Agents has been created in respect
of any of the transactions contemplated by this Agreement, irrespective of whether any
of the Placements Agents has advised or is advising the Company on other matters;
	 
	 	(b)	 	The price of the Shares set forth in this Agreement was established by the
Company following discussions and arms-length negotiations with the Representative, and
the Company is capable of evaluating and understanding, and understands and accepts,
the terms, risks and conditions of the transactions contemplated by this Agreement;
	 
	 	(c)	 	The Company has been advised that the Placement Agents and their affiliates are
engaged in a broad range of transactions which may involve interests that differ from
those of the Company and that the Placement Agents have no obligation to disclose such
interests and transactions to the Company by virtue of any fiduciary, advisory or
agency relationship; and

29

 

	 	(d)	 	The Company waives, to the fullest extent permitted by law, any claims it may
have against the Placement Agents for breach of fiduciary duty or alleged breach of
fiduciary duty and agrees that the Placement Agents shall have no liability (whether
direct or indirect) to the Company in respect of such a fiduciary duty claim or to any
person asserting a fiduciary duty claim on behalf of or in right of the Company,
including stockholders, employees or creditors of the Company.

13. Notices. All communications hereunder, except as herein otherwise specifically
provided, shall be in writing and, if sent to you, shall be mailed, delivered or telegraphed and
confirmed to the Placement Agents care of Oppenheimer & Co. Inc., 125 Broad Street, New York, New
York 10004, Attention: Dennis MacNamara, General Counsel, facsimile: (212) 668-8081, with a copy to
Peter S. Kolevzon, Esq., Kramer Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New
York, New York 10036, facsimile: (212) 715-8000; if sent to the Company shall be mailed, delivered
or telegraphed and confirmed to Citizens, Inc., 400 East Anderson Lane, Austin, Texas 78752,
Attention: President, facsimile: (512) 836-9785, with a copy to Reid Godbolt, Esq., Jones & Keller,
P.C., 1625 Broadway, 16th Floor, Denver, Colorado 80202, facsimile: (303) 573-0769.

14. Definitions of Certain Terms. The terms which follow, when used in this Agreement,
shall have the meanings indicated.

“Business Day” shall mean any day other than a Saturday, a Sunday, a legal holiday, a day on
which banking institutions or trust companies are authorized or obligated by law to close in
New York City or any day on which the New York Stock Exchange is not open for trading.

“Effective Date” shall mean each date and time that the Registration Statement (and any
post-effective amendment or amendments thereto) became or becomes effective.

“To the Company’s knowledge” and words of similar import shall mean the Company’s actual
knowledge based on reasonable due diligence.

15. Governing Law. This Agreement shall be governed by and construed in accordance with
the laws of the State of New York.

16. Placement Agents’ Information. The parties hereto acknowledge and agree that, for all
purposes of this Agreement, the Placement Agents’ Information consists solely of the statements
concerning the Placement Agents contained in the first paragraph under the heading “Plan of
Distribution” in the Prospectus Supplement.

17. Partial Unenforceability. The invalidity or unenforceability of any Section, paragraph
or provision of this Agreement shall not affect the validity or enforceability of any other
Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement
is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such
minor changes (and only such minor changes) as are necessary to make it valid and enforceable.

30

 

18. General. This Agreement constitutes the entire agreement of the parties to this
Agreement and supersedes all prior written or oral and all contemporaneous oral agreements,
understandings and negotiations with respect to the subject matter hereof. In this Agreement, the
masculine, feminine and neuter genders and the singular and the plural include one another. The
section headings in this Agreement are for the convenience of the parties only and will not affect
the construction or interpretation of this Agreement. This Agreement may be amended or modified,
and the observance of any term of this Agreement may be waived, only by a writing signed by the
Company and the Placement Agents.

19. Counterparts. This Agreement may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto and hereto were upon
the same instrument.

20. Consent to Act as Representative. Oppenheimer & Co. Inc. (“Oppenheimer”), consents and
agrees that Oppenheimer will act as Representative of the Placement Agents under this Agreement and
with respect to the sale of the Shares. Accordingly, each of KeyBanc Capital Markets Inc. and
Oppenheimer authorizes Oppenheimer to manage the Offering and the sale of the Shares and to take
such action in connection therewith as Oppenheimer in its sole discretion deems appropriate or
desirable.

[Signature Page Follows]

31

 

     If the foregoing is in accordance with your understanding of the agreement between the Company
and the Placement Agents, kindly indicate your acceptance in the space provided for that purpose
below.

	 	 	 	 	 	 	 
	 	 	Very truly yours,	 	 
	 
	 	 	 	 	 	 
	 	 	CITIZENS, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

Name:
	 	 
	 

	 	 	 	Title:	 	 

Accepted as of

the date first above written:

OPPENHEIMER & CO. INC.

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 

Name:
	 	 
	 

	 	Title:	 	 

32

 

Schedule I

Placement Agents

     OPPENHEIMER & CO. INC.

     KEYBANC CAPITAL MARKETS INC.

33

 

Schedule II

Pricing Information

The Pricing Information consists of the initial price to the public of the Shares.

34

 

Schedule III

Issuer Free Writing Prospectus(es)

The pricing supplement / term sheet being filed by the Company with the Commission pursuant to Rule
433 of the Regulations on November 29, 2007.

35

 

Schedule IV

List of Subsidiaries

CICA Life Insurance Company of America (CICA) (f/k/a Citizens Insurance Company of America), a
Colorado corporation which is 100% owned by the Company.

CICA has the following Subsidiaries:

	 	•	 	Citizens National Life Insurance Company (CNLIC) (f/k/a Combined Underwriters Insurance
Company (Combined)), a Texas corporation which is 100% owned by CICA.
	 
	 	•	 	Computing Technology, Inc. (CTI), a Colorado corporation which is 100% owned by CICA.
	 
	 	•	 	Funeral Homes of America, Inc. (FHA), a Louisiana corporation which is 100% owned by
CICA.
	 
	 	•	 	Insurance Investors, Inc. (III), a Texas corporation which is 100% owned by CICA.
	 
	 	•	 	Security Plan Life Insurance Company (SPLIC), a Louisiana corporation which is 100%
owned by CICA.

	 	•	 	Security Plan Fire Insurance Company (SPFIC), a Louisiana corporation which is 100%
owned by SPLIC.

CICA has the following affiliate:

	 	•	 	Integrity Capital Corporation (ICC), an Indiana corporation which is 13.1% owned by
CICA.

	 	•	 	Integrity Capital Insurance Company (ICIC), an Indiana corporation which is 100%
owned by ICC.

36

 

Exhibit A

[Form of Subscription Agreement]

 

37

 

Exhibit B

[Form of Lock-Up Agreement]

 

38

 

Exhibit C

[Form of Opinion of Company’s Counsel]

 

39exv10w14xcy

 

Exhibit 10.14(c)

AWARD AGREEMENT OF RESTRICTED STOCK WITH TIME-LAPSE VESTING

UNDER THE ATMOS ENERGY CORPORATION

1998 LONG-TERM INCENTIVE PLAN

     This Award Agreement of Restricted Stock with time-lapse vesting is dated as of                     ,
                    , by and between, Atmos Energy Corporation, a Texas and Virginia corporation (the
“Company”), and [name of employee], pursuant to the Company’s 1998 Long-Term Incentive Plan (the
“Plan”). Capitalized terms that are used, but not defined, in this document shall have the meaning
set forth in the Plan.

     Pursuant to authorization by the Human Resources Committee of the Board of Directors (the
“Committee”), which has been designated by the Board of Directors of the Company to administer the
Plan, the parties agree as follows.

1. Grant of Shares.

     The Company hereby grants to the Grantee a total of [number] shares of Common Stock of the
Company (“Shares’’) for no consideration from the Grantee, with the restrictions set forth below.

2. Legends on Certificates.

     Each certificate representing the Shares shall be registered in the name of the Grantee and
shall bear the following legend, or a similar legend deemed by the Company to constitute an
appropriate notice of the provisions hereof (any such certificate not having such legend shall be
surrendered upon demand by the Company and so endorsed):

     On the face of the certificate:

“Transfer of this stock is restricted in accordance with conditions
printed on the reverse of this certificate.”

     On the reverse:

“The shares of stock evidenced by this certificate are subject to
and transferrable only in accordance with that certain Atmos Energy
Corporation 1998 Long-Term Incentive Plan, a copy of which is on
file at the principal office of the Company in Dallas, Texas. No
transfer or pledge of the shares evidenced hereby may be made except
in accordance with and subject to the provisions of said Plan. By
acceptance of this certificate, any holder, transferee or pledgee
hereof agrees to be bound by all of the provisions of said Plan.”

3. Restrictions on Alienation of Shares.

     Shares awarded hereunder may not be sold, transferred, pledged, assigned, or otherwise
alienated in any manner, whether voluntarily, by operation of law, or otherwise, until

 

 

the restrictions on the Shares are removed in the manner provided for below and the Shares are
delivered to the Grantee.

4. Forfeiture of Shares.

     Shares will be forfeited if, prior to the removal of restrictions on the Shares awarded
hereunder, the Grantee terminates employment for any reason other than death, disability,
involuntary termination (other than termination for cause) or retirement (but not before attaining
the age of 55). Each Grantee, by his or her acceptance of the Shares, shall irrevocably grant to
the Company a power of attorney to transfer any Shares forfeited to the Company and agrees to
execute any documents requested by the Company in connection with such forfeiture and transfer.
Such provisions with respect to forfeited Shares shall be specifically performable by the Company
in a court of equity or law. Upon any forfeiture, all rights of the Grantee with respect to the
forfeited Shares shall cease and terminate, without any further obligation on the part of the
Company.

5. Removal of Restrictions due to Death, Disability, Involuntary Termination or Retirement.

     At the time and on the date of the Grantee’s death, disability, involuntary termination (other
than termination for cause) or retirement (but not before attaining the age of 55) while employed
by the Company or Subsidiary, all restrictions placed on each Share awarded shall be removed and
such Shares shall be delivered to the Grantee or to his legal representatives, beneficiaries, or
heirs. From and after such date, the Grantee or the Grantee’s estate, personal representative or
beneficiary, as the case may be, shall have full rights of transfer or resale with respect to such
stock subject to applicable state and federal regulations. The restrictions on Shares awarded
shall not be removed due to the Grantee’s retirement prior to attaining the age of 55, unless such
removal is expressly approved by the Commitee.

6. Custody of Share Certificates.

     Share certificates representing the number of Shares awarded shall be registered in the
Grantee’s name, but the certificates representing the Shares shall be held in the custody of the
Company for the Grantee’s account. During such time, the Grantee shall have all of the rights of a
shareholder of the Company with respect to the Shares, including the right to vote the Shares. All
dividends and distributions (other than stock dividends and distributions) on Shares held in the
custody of the Company shall be paid to the Grantee, however, regardless of the fact that the
Shares are being held in behalf of the Grantee. Any new, additional, or different shares or
securities issued (due to a stock split, stock dividend, or other stock distribution) with respect
to the Shares previously awarded under the Plan shall be held by the Company as additional Shares
for the Grantee’s account and shall have the same restrictions as the underlying Shares with
respect to which such new, additional, or different shares or securities were issued. At such time
as restrictions are removed from any portion of the Shares held by the Company for the Grantee,
certificates representing such Shares shall be delivered free of all restrictions to the Grantee or
to the Grantee’s legal representatives, beneficiaries, or heirs.

7. Adjustment Upon Changes in Stock.

     If there shall be any change in the number of shares of Common Stock of the Company
outstanding resulting from subdivision, combination, or reclassification of shares, or through
merger, consolidation, reorganization, recapitalization, stock dividend, stock split or other
change in the corporate structure, an appropriate adjustment in the number of Shares with

 

 

respect to which restrictions have not lapsed shall be made by the Committee.

8. Removal of Restrictions.

     The Grantee shall be entitled to delivery of the Shares, free and clear of all restrictions,
if the Grantee has been an employee of the Company or Subsidiary with continuous service of three
years from the date of the Grant. Notwithstanding the foregoing provision, the Grantee shall, in
the event of a “Change of Control” of the Company, as such term is defined in Section 2.6 of the
Plan, receive free of restriction all Shares granted hereunder within 60 days after the time such
Change of Control is deemed to have occurred. Notwithstanding anything contained in this section
to the contrary, the Shares acquired by virtue of this Grant may not be sold during the first six
(6) months after the date hereof if that would subject the Grantee to liability under Section 16 of
the Securities Exchange Act of 1934, as amended.

9. Stock Withholding Requirement.

     Upon the removal or lapse of the restrictions on the Shares, the number of Shares issuable by
the Company to the Grantee shall be subject to applicable withholding requirements for income and
employment taxes arising from the removal or lapse of the restrictions on the Shares.

     IN WITNESS WHEREOF, the Company and the Grantee have executed this Agreement as of the date
first written above.

	 	 	 	 	 	 	 	 	 	 	 
	GRANTEE:	 	 	 	 	 	ATMOS ENERGY CORPORATION	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Signature:

	 	 	 	 	 	By:	 	 	 	 
	 

	 	 

	 	 	 	 	 	 

Robert W. Best
	 	 
	 

	 	 	 	 	 	 	 	Chairman, President and Chief	 	 
	Printed Name:

	 	 	 	 	 	 	 	Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]